DocSym
β
Searchsearch
Search
(N42.2) Atrophy of prostate
More details coming soon
87 013 in individuals diagnosis atrophy of prostate confirmed
6 339 deaths with diagnosis atrophy of prostate
7% mortality rate associated with the disease atrophy of prostate
Diagnosis atrophy of prostate is diagnosed Prevalent in Men Only
87 013
Men receive the diagnosis atrophy of prostate
6 339 (7.3 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
0
Women receive the diagnosis atrophy of prostate
0 (No mortality)Died from this diagnosis.
Risk Group for the Disease atrophy of prostate - Men aged 65-69 and Women aged 0
In Men diagnosis is most often set at age 0-1, 5-95+
Less common in men the disease occurs at Age 0-5Less common in women the disease occurs at Age 0-95+
No Cases of the Disease Atrophy of prostate identified in Men
Disease Features atrophy of prostate
Absence or low individual and public risk
Atrophy of prostate - what does this mean
Atrophy of the prostate occurs when the cells of the prostate gland shrink and die due to a decrease in hormones, such as testosterone, or due to other factors such as aging, infection, or inflammation. this can lead to symptoms such as difficulty urinating, decreased sexual drive, and incontinence.
What happens during the disease - atrophy of prostate
Atrophy of the prostate is a common condition that occurs when the prostate gland shrinks in size due to a decrease in androgen production. this decrease in androgen production can be caused by aging, hormonal imbalances, or certain medications. the decrease in androgen production leads to a decrease in the number of cells in the prostate, resulting in the prostate shrinking in size. this can lead to urinary symptoms such as increased frequency, urgency, and difficulty in starting or stopping urination.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical Examination
- Digital Rectal Examination (DRE)
- Prostate Specific Antigen (PSA) Blood Test
- Ultrasound
- Transrectal Ultrasound (TRUS)
- Prostate Biopsy
- Cystoscopy
Treatment and Medical Assistance
Main Goal: Treating Atrophy of Prostate
- Regularly monitor prostate-specific antigen (PSA) levels
- Regularly monitor urinary symptoms
- Administer androgen therapy
- Administer 5-alpha reductase inhibitors
- Administer alpha-blockers
- Administer finasteride
- Administer dutasteride
- Administer tamsulosin
- Administer terazosin
- Administer alfuzosin
- Administer doxazosin
- Administer antimuscarinics
- Administer phytotherapy
- Administer herbal medicines
- Administer lifestyle changes
- Administer dietary changes
- Administer physical activity
- Administer stress management techniques
5 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Atrophy of prostate - Prevention
The prevention of atrophy of the prostate can be achieved through a combination of lifestyle changes, such as maintaining a healthy weight, eating a balanced diet, and exercising regularly, as well as avoiding certain medications and supplements that may contribute to the condition. additionally, regular prostate exams and screenings can help detect early signs of the condition, allowing for timely and effective treatment.